文献速递神经肿瘤

低级别胶质瘤中microRNA的表达及预后价值取决于IDH1/2状态

Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status.
PubMed 文献 · J Neurooncol · 2017-01-16

该研究基于癌症基因组图谱数据库中447例低级别胶质瘤样本,分析IDH1/2突变状态与microRNA表达及预后的关系。结果显示IDH1/2突变状态对miRNA表达模式的影响大于组织学和其他基因组特征,且不同IDH1/2状态组间无相同预后意义的miRNA。在IDH1/2突变型低级别胶质瘤中建立的四miRNA风险分类器可在训练集和验证集中独立区分高/低危病例,其敏感性和特异性优于单个miRNA和传统预后因素。

要点

  • IDH1/2突变状态对miRNA表达模式的影响大于组织学和其他基因组特征。
  • 不同IDH1/2突变状态组间不存在具有相同预后意义的miRNA。
  • 四miRNA风险分类器可用于IDH1/2突变型低级别胶质瘤的风险分层。

核心结论

  • IDH1/2突变状态对低级别胶质瘤的miRNA表达和预后判断有显著影响,基于四miRNA的风险分类器可用于IDH1/2突变型低级别胶质瘤的风险分层。

研究设计与样本

  • 回顾性分析癌症基因组图谱数据库中447例具有可用临床和基因组信息的低级别胶质瘤样本。
  • 将IDH1/2突变样本(n=366)随机分为训练集和验证集,以建立并确认基于四miRNA的风险分类器。

主要发现

  • IDH1/2突变状态对miRNA表达模式的影响大于组织学和其他基因组特征,361/487(74%)的miRNA根据IDH1/2突变状态存在差异表达。
  • 不同IDH1/2突变状态组间不存在具有相同预后意义的miRNA。
  • 在IDH1/2突变型低级别胶质瘤中建立的四miRNA风险分类器(miR-10b、miR-130b、miR-1304和miR-302b)可在训练集和验证集中独立区分高或低危预后不良病例。
  • 该风险分类器在敏感性和特异性方面优于单个miRNA和传统预后因素。
  • 生物信息学分析表明高危样本较低危样本有更高的有丝分裂活性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Histological and genomic characteristics are widely used in glioma management and research. This study investigated their relationship to the expression and prognostic value of microRNAs (miRNAs) in lower-grade glioma (LGG). A total of 447 LGG samples with available clinical and genomic information from The Cancer Genome Atlas database were reviewed. Samples with isocitrate dehydrogenase (IDH) 1/2 mutations (n = 366) were randomly divided into training and validation sets to establish and confirm a four-miRNA-based risk classifier. We found that IDH1/2 mutation status had greater impact than histological and other genomic features on miRNA expression patterns; 361/487 (74%) of miRNAs were differentially expressed according to IDH1/2 mutation status. Importantly, there were no miRNAs with the same prognostic significance among groups with different IDH1/2 mutation status. For IDH1/2-mut LGG, a four-miRNA risk classifier (miR-10b, miR-130b, miR-1304, and miR-302b) was established that could independently distinguish cases as high or low risk of poor prognosis in both training and validation sets. The risk classifier outperformed individual miRNAs and traditional prognostic factors in terms of sensitivity and specificity. Bioinformatic analyses indicated that high-risk samples were more mitotically active than low-risk samples. Taken together, IDH1/2 mutation status had a significant influence on miRNA expression and prognostication in LGG. The four-miRNA-based risk classifier can be used for risk stratification of IDH1/2-mut LGG.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Cheng W, Ren X, Zhang C, et al. Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status. J Neurooncol. 2017. PMID: 28091987. doi:10.1007/s11060-016-2368-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。